PF-Atlas › Clinical Trials › NCT04579211
Prospective Analysis of Urine LAM to Eliminate NTM Sputum Screening
urine lipoarabinomannan · Not specified
Registry ID
NCT04579211
Phase
Not specified
Status
Enrolling by invitation
Drug / intervention
urine lipoarabinomannan (LAM)
Sponsor
Jerry A. Nick, M.D.
Start
2020-12-10
About this trial
urine lipoarabinomannan is evaluated in NCT04579211, a idiopathic pulmonary fibrosis study sponsored by Jerry A. Nick, M.D.. Current status: Enrolling by invitation.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04579211 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.